State of the art session: Respiratory infections

Symposium
Chairs: J. Chalmers (Dundee (Angus), United Kingdom), G. Bothamley (London, United Kingdom)
Aims: to present the latest approaches to preventing development of active tuberculosis through treatment of latent disease; to understand the role of the fungal microbiome and its effect on lung immunity; to prevent nosocomial spread of non-tuberculous mycobacteria within the cystic fibrosis clinic, and nosocomial pneumonias, including ventilator-associated pneumonia, by adherence to evidence-based guidelines;
Ceremony for ERS Research Award: Innovation in Non-Tuberculous Mycobacteria Science and Medicine
G. Bothamley (London, United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Latent tuberculosis infection: a new paradigm
M. Behr (Montréal, Canada)
WebcastSlide presentation
WebcastSlide presentation
The fungal microbiome and its role in bronchiectasis
S. Chotirmall (Singapore, Singapore)
WebcastSlide presentation
WebcastSlide presentation
Non-tuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis
C. Andrejak (Amiens, France)
WebcastSlide presentation
WebcastSlide presentation
Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia
A. Torres (Barcelona, Spain)
WebcastSlide presentation
WebcastSlide presentation